Nienke Z. Borren

Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease

Jonathan Lee, Damian R. Plichta, Larson Hogstrom et al. · Cell Host & Microbe · 2021 · 216 citations · Full text

Life Sciences, Immunology, Microbiology +14

Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study

Tomer Adar, David M. Faleck, Saranya Sasidharan et al. · Alimentary Pharmacology & Therapeutics · 2019 · 97 citations

Pharmacy, Geriatric Medicine, Pharmacotherapy +17

Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases

Betsy W. Stevens, Nienke Z. Borren, Gabriella Velonias et al. · Digestive Diseases and Sciences · 2016 · 67 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Alterations in Fecal Microbiomes and Serum Metabolomes of Fatigued Patients With Quiescent Inflammatory Bowel Diseases

Nienke Z. Borren, Damian R. Plichta, Amit D. Joshi et al. · Clinical Gastroenterology and Hepatology · 2020 · 64 citations

Life Sciences, Immunology, Microbiology +17

Longitudinal Trajectory of Fatigue With Initiation of Biologic Therapy in Inflammatory Bowel Diseases: A Prospective Cohort Study

Nienke Z. Borren, William Tan, Francis Colizzo et al. · Journal of Crohn s and Colitis · 2019 · 57 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17